SASH1 and neoplasm: SAM and SH3 domain containing 1 (SASH1) was initially identified as a putative tumour suppressor gene, based on detection of significantly lower mRNA levels in lung, thyroid and colorectal cancers compared to adjacent normal tissue [2, 3].